Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 10Phase 3 9Phase 1/2 8Phase NA 3Phase EARLY_PHASE1 3Phase 2/3 3

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 2Resectable Pancreatic Cancer 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × folfirinox × Clear all
NCT04472910 2026-03-12

NeoPancOne

University Health Network, Toronto

Phase NA Active not recruiting
84 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

NCT03690323 2018-10-01

PELICAN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown
228 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01771146 2017-01-31

Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

Baylor Research Institute

Phase NA Unknown
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡